Inactive Instrument

CRH Medical Corporation

Equities

CRH

CA12626F1053

CRH Medical Corporation Provides Earnings Guidance for the Third Quarter Ending September 30, 2017

September 22, 2017 at 08:43 am EDT

CRH Medical Corporation provided earnings guidance for the third quarter ending September 30, 2017. For the period the company expects total revenue to be approximately USD 22.7 million. Adjusted Operating EBITDA attributable to shareholders for the period is estimated to be approximately USD 7.3 million.

Latest news about CRH Medical Corporation

CRH Medical Corporation acquired CarePlus Management, LLC for CAD 0.05 million.	23-07-12	CI
Graphium Health, LP announced that it has received funding from CRH Medical Corporation	23-06-21	CI
An unknown buyer acquired 51% stake in Western Ohio Sedation Associates, LLC from CRH Medical Corporation for CAD 10.9 million.	23-05-11	CI
United Digestive acquired West Florida Anesthesia Associates, LLC from CRH Medical Corporation for $12.4 million.	22-11-09	CI
CRH Medical Corporation acquired Grand Canyon Anesthesiology Consultants, LLC for $6.5 million.	22-10-16	CI
CRH Medical Opens Its First Hemorrhoid Banding Clinic in the Chicago, IL	22-03-15	CI
CRH Medical Corporation acquired Greater Connecticut Anesthesia Associates, LLC.	22-03-14	CI
CRH Medical Corporation acquired Utah Anaesthesia.	22-01-19	CI
Update: WELL Health Down 1.4% as Subsidiary Acquires 51% of Greater Washington Anesthesia Associates	21-08-03	MT
WELL Health Technologies : Subsidiary Acquires 51% of Greater Washington Anesthesia Associates	21-08-03	MT
CRH Medical Corporation acquired GREATER WASHINGTON ANESTHESIA ASSOCIATES, LLC.	21-08-02	CI
WELL Health Technologies : Unit CRH Medical Acquires Majority Stake in Two Anesthesia Practices	21-05-27	MT
CRH Medical Corp Mulls Acquisitions	21-05-10	CI
CRH Medical : WELL Health Unit CRH Medical Buys 85% Stake in New England Anesthesia Associates; Toronto Bourse OKs Normal Course Issuer Bid	21-05-10	MT
Well Health Brief: Says Its CRH Medical Buying New England Anesthesia Associates; Separately, WELL Health Announces Approval of Normal Course Issuer Bid	21-05-10	MT
CRH Medical Corporation acquired 85% stake in New England Anesthesia Associates LLC.	21-05-09	CI
WELL Health Technologies : CRH Medical, Fresh Off Purchase by WELL Health, Secures $300 Million Credit Line from JPMorgan-led Syndicate	21-04-26	MT
WELL Health Reports on CRH Medical's Upsized USD 300 Million Revolving Credit Facility with JP Morgan	21-04-26	CI
CRH Medical Corporation(TSX:CRH) dropped from S&P Global BMI Index	21-04-23	CI
WELL Health Technologies : Completes US$286.6 Million Purchase of CRH Medical	21-04-22	MT
WELL Health Technologies Corp. completed the acquisition of CRH Medical Corporation.	21-04-21	CI
Well Health Brief: Upon Closing, Subscription Receipts From WELL's Prior Announced C$302.5 Million Equity Offering Will Be Exchanged Into Common Shares of WELL	21-04-19	MT
Well Health Brief: Transaction Expected To Be Completed On Or About April 22, 2021 and Represents WELL's Largest Buy to Date With a Total Transaction Value of Near US$369.2 Million	21-04-19	MT
Well Health Brief: Says CRH Medical Corp.'s Securityholders Approved the Acquisition By a Subsidiary of WELL Health at the Special Meeting of Friday April 16, 2021	21-04-19	MT
Well Health Brief: Provides an Update on its Proposed Acquisition of CRH Medical	21-04-19	MT

Chart CRH Medical Corporation

Duration

Period

More charts

Company Profile

CRH Medical Corporation is a Canada-based healthcare products and services company. The Company is focused on providing gastroenterologists throughout the United States with services and products for the treatment of gastrointestinal diseases. The Company provides anesthesia services for patients undergoing endoscopic procedures in ambulatory surgical centers. In addition, the Company owns the CRH O'Regan System, a single-use, disposable, hemorrhoid banding technology that provides gastrointestinal is a single use, disposable, hemorrhoid banding technology for treating all hemorrhoid grades. The Company distributes the O'Regan System, treatment protocols, operational and marketing expertise as a complete package directly to gastroenterology practices, creating meaningful relationships with the gastroenterologists it serves.

Sector

More about the company